InvestorsHub Logo
Followers 98
Posts 11521
Boards Moderated 0
Alias Born 05/29/2014

Re: SPecPrototype post# 30784

Monday, 12/16/2019 8:24:28 AM

Monday, December 16, 2019 8:24:28 AM

Post# of 52105
In my opinion, Symtomax is going to buy GCAN so they get onto a more important stock exchange than the Canadian Stock exchange and they will get the Patent rights to what I previously posted!!!! That is what I am seeing/speculating!!!

Symtomax currently owns one of the largest legal cannabis cultivation areas in Europe, with a planned production facility site in Portugal totaling 1,830,000 square meters. In addition to its 40 years in medical cannabis, it has extensive international experience in operations, capital markets, corporate finance, law, and healthcare services. In April 2019, Symtomax announced plans to list on the Canadian Stock Exchange (CSE)



.

"Patience is bitter, but its fruit is sweet."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GCAN News